Home | About Us | Grants | Resources | News & Events | Community

Vision: We may not be there yet, but we are closer than we were yesterday.


About Us
arrowHistory & Background

arrowGrant Opportunities
arrowGrant Process
arrowASN Co-Grants
arrow2015 Grant Recipient
2013 Grant Recipient
arrowTranslational Research

arrowPatient Registries
arrowMedical Experts
arrowBio Banks

News & Events
arrow2018 MN Conference in Bergamo
HFE Gene Linked to MN
arrowCureGN Study at Columbia
Protein Linked to Kidney Failure arrow
arrowNIH Renews NEPTUNE Funding
Childhood Stress not trigger for MS
arrowLevin succeeds Remuzzi at ISN

arrowSalant receives Hamburger Award
arrowDrug for MS & Alzheimer's
arrowNeurons & Salt
arrowAutoimmune-Allergy Connection
arrowA Cause of Recurrent MN
arrowBlood Test Detects Kidney Rejection
Genotyping of Risk Alleles
arrowLink to Gene Variants

arrowBlood Test to Detect MN
arrowMN, an Autoimmune Disease
arrowKey Molecule Impacts Mice
arrowLa Jolla Institute
arrowGluten Specific T-cells
arrowHuman Gene Pool
arrowVitamin D & Clinical Outcomes
arrowBovine Serum Albumen
Variations in HLA-DQA1 & PLA2R1 regions
arrowKlotho and Kidney Disease
arrowLink between MN and Milk (NEJM)

arrowASN News Release
arrowMario Negri News Release

arrowHyper-IgG4 Syndrome News Release
arrowAdvances in Kidney Disease (RSS)
arrowKidney Disease News (RSS)
arrowNew Patents (RSS)
arrowScience Daily (RSS)
arrowUpcoming Events
arrowEvents Archive

arrowPublic Service Announcement


Our Vision

We may not be there yet, but we are closer than we were yesterday.

Our Mission

Understanding and Overcoming Genetic Medical Conditions

The Halpin Foundation seeks to aid the medical community in understanding and overcoming genetic conditions. To achieve the most impact with our funds, we prioritize our grants into two targeted goal areas: kidney disease research and autoimmune disease research. Today, autoimmune diseases are typically treated with immunosuppression -- medication that decreases the immune response and does not address the underlying genetic dispositions of the patient. We are encouraging researchers to identify the genetic basis for autoimmune diseases and kidney diseases such as Membranous Nephropathy (MN), which is often idiopathic.

Accomplishing Our Goals

To accomplish these goals, we use a variety of strategies. We support training, education, registries, research (including biomedical and genetic research), and projects that demonstrate the effective delivery of health care services. Rather than paying for individual care, we concentrate on health care systems and the conditions that promote better health now and for future generations. We believe that renal physiology, which is the study of kidney function, and nephrology, which is the specialty concerned with kidney diseases, both will make significant advances with the a greater understanding of the role of genetics and the application of personalized medications.

The Halpin Foundation supports a multi-disciplinary approach, which encourages translational research. As a result, grantees may be as varied as the challenges they tackle. They include: hospitals; independent physicians/researchers; medical, nursing, and public schools; professional associations; research organizations; government and community groups.

The Foundation is a non-profit medical research organization. No salaries, overhead or expenses are drawn and to that end one hundred percent of our funding goes toward the advancements we back.